Tyvaso
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 5279, Cary, North Carolina, 27512...Website
www.tyvaso.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Tyvaso
TYVASO offers two inhaled treatments, TYVASO® (treprostinil) Inhalation Solution and TYVASO DPI® (treprostinil) Inhalation Powder, designed for patients suffering from pulmonary arterial hypertension (PAH WHO Group 1) and pulmonary hypertension associated with interstitial lung disease (PH-ILD WHO Group 3). These products aim to improve the ability to exercise for individuals facing these conditions. The company provides detailed clinical information and safety guidelines tailored for healthcare professionals. Their intended clients include patients with specific forms of pulmonary hypertension and the healthcare providers who treat them.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tyvaso your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Tyvaso has recently received funding, and reach out quickly before it becomes old news!
Check out if Tyvaso is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Tyvaso had a recent Job posting/layoffs
Product Launch: Get notified when Tyvaso launches new products
Earning: See what the market has to say on Tyvaso recently announced quarterly report
Website visits: Recent activity has been detected on your website
Tyvaso, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Tyvaso has new funding data
Congratulate Masked Content for being promoted to Masked Content at Tyvaso
Recommended Actions
Reach out to Masked Content who joined Tyvaso as Masked Content
Find 2 more new buyers
Compare Similar Companies to Tyvaso
Compare insights from companies similar to Tyvaso, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Tyvaso is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tyvaso is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tyvaso.
Tyvaso Tech Stack
A closer look at the technologies used by Tyvaso
Tyvaso News & Media
United Therapeutics Announces the Publication of Tyvaso DPI™ BREEZE Clinical and Long-term Data in the Journal Pulmonary Circulation
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the publication of additional clinical and long-term safety data from the BREEZE study evaluating Tyvaso DPI™ (treprostinil) in patients with pulmonary arterial hypertension (PAH) in the journal Pulmonary Circulation. The publication evaluated the BREEZE study and its ongoing optional extension phase (OEP), and concluded: Tyvaso DPI’sUnited Therapeutics' (UTHR) Tyvaso DPI NDA Gets CRL From FDA (Revised)
United Therapeutics' (UTHR) new drug application for Tyvaso DPI to treat PAH & PH-ILD fails to secure approval from the FDA. The stock declines resultantly.United Therapeutics Provides an Update on the Progress of the Tyvaso DPI™ New Drug Application
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 18, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced an update on the U.S. Food and Drug Administration (FDA) review of the new drug application (NDA) for Tyvaso DPI™, for the treatment of...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tyvaso
Sign Up For FreeTo access detailed company insights
TYVASO offers two inhaled treatments, TYVASO® (treprostinil) Inhalation Solution and TYVASO DPI® (treprostinil) Inhalation Powder, designed for patients suffering from pulmonary arterial hypertension (PAH WHO Group 1) and pulmonary hypertension associated with interstitial lung disease (PH-ILD WHO Group 3). These products aim to improve the ability... Read More
